Gait and its assessment in psychiatry

Psychiatry (Edgemont)

Volumn 7, Issue 7, 2010, Pages 38-43

  Sanders, Richard D ^a   Gillig, Paulette Marie ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Ambulation; Balance; Gait; Neuropsychiatric assessment

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; GABAPENTIN; MECLOZINE; METOCLOPRAMIDE; NEUROLEPTIC AGENT; PROCHLORPERAZINE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TRANQUILIZER; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

APRAXIA; ARTICLE; ATAXIA; BALANCE DISORDER; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; FALLING; FLAPPING TREMOR; FRONTAL LOBE; GAIT; GAIT DISORDER; HUMAN; HYPOTENSION; MENTAL DISEASE; MOTOR CONTROL; MOTOR CORTEX; NEUROLOGIC DISEASE; PARKINSONISM; POLYPHARMACY; PREFRONTAL CORTEX; SCHIZOPHRENIA; SIDE EFFECT; VESTIBULAR DISORDER; WALKING;

EID: 77956115416     PISSN: 15505952     EISSN: 15555194     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Della Sala S, Francescani A, Spinnler H. Gait apraxia after bilateral supplementary motor area lesion. J Neurol Neurosurg Psychiatry. 2002;72:77-85.
2. Strike SC, Taylor MJ. The temporal-spatial and ground reaction impulses of turning gait: Is turning symmetrical? Gait Posture. 2009;29:597-602.
3. Marchetti GF, Whitney SL, Blatt PJ, et al. Temporal and spatial characteristics of gait during performance of the Dynamic Gait Index in people with and people without balance or vestibular disorders. Phys Ther. 2008;88:640-651.
4. Palliyath S, Hallet M, Thomas SL, Lebiedowska MK. Gait in patients with cerebellar ataxia. Mov Disord. 1988;6:958-964.
5. Zehr EP, Duysens J. Regulation of arm and leg movement during human locomotion. Neuroscientist. 2004;10:347-361.
6. Azevedo C, Espiau B, Amblard B, Assaiante C. Bipedal locomotion: toward unified concepts in robotics and neuroscience. Biol Cybern. 2007;96:209-228.
7. Passingham RE. Functional specialization of the supplementary motor area in monkeys and humans. Adv Neurol. 1996;70:105-116.
8. Thompson P, Nutt J. Frontal and higher level gait disorders. In: Bronstein A, Brandt T, Woollacott M, Nutt J (eds). Clinical Disorders of Balance, Posture and Gait, Second Edition. London: Arnold; 2004:216-221.
9. Baezner H, Blahak C, Poggesi A, et al. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology. 2008;70:935-942.
10. Silbert L, Nelson C, Howieson D, et al. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology. 2008;71:108-113.
11. Thompson P. Higher level gait disorders. Curr Neurol Neurosci Rep. 2007;7:290-294.
12. Onen F, Henry-Feugeas MC, Roy C, et al. Mobility decline of unknown origin in mild cognitive impairment: an MRI-based clinical study of the pathogenesis. Brain Res. 2008;1222:79-86.
13. Snijders A, van de Warrenburg, Giladi N, Bloem B. Neurological gait disorders in elderly people: clinical approach and classification. Lancet Neurol. 2007;6:63-74.
14. Snijders A, Verstappen C, Munneke M, Bloem B. Assessing the interplay between cognition and gait in the clinical setting. J Neural Transm. 2007;114:1315-1321.
15. Srygley JM, Mirelman A, Herman T, et al. When does walking alter thinking? Age and task associated findings. Brain Res. 2009;1253:92-99.
16. Louis ED, Tang MX, Mayeux R. Parkinsonian signs in older people in a community-based study: risk of incident dementia. Arch Neurol. 2004;61:1273-1276.
17. Inzitari M, Newman AB, Yaffe K, et al. Gait speed predicts decline in attention and psychomotor speed in older adults: the health aging and body composition study. Neuroepidemiology. 2007;29:156-162.
18. Verghese J, Wang C, Lipton R, et al. Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry. 2007;78:929-935.
19. Guttmann CR, Benson R, Warfield SK, et al. White matter abnormalities in mobility-impaired older persons. Neurol. 2000;54:1277-1283.
20. Charness ME, Simon RP, Greenberg DA. Ethanol and the nervous system. N Engl J Med. 1989;321:442-454.
21. Flyckt L, Sydow O, Bjerkenstedt L, et al. Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls. Psychiatry Res. 1999;86:113-129.
22. Putzhammer A, Heindl B, Broll K, et al. Spatial and temporal parameters of gait disturbances in schizophrenic patients. Schizophr Res. 2004;69:159-166.
23. Sullivan EV, Rosenbloom MJ, Pfefferbaum A. Balance and gait deficits in schizophrenia compounded by the comorbidity of alcoholism. Am J Psychiatry. 2004;161:751-755.
24. Jeon HJ, Cho MJ, Cho SJ, et al. Quantitative analysis of ataxic gait in patients with schizophrenia: the influence of age and visual control. Psychiatry Res. 2007;152:155-164.
25. Lemke M, Wendorff T, Mieth B, et al. Spatiotemporal gait patterns during over ground locomotion in major depression compared with healthy controls. J Psychiatr Res. 2000;34:277-283.
26. Bader JP, Buhler J, Endrass J, et al. Muscle strength and gait patterns of depressed people. Nervenarzt. 1999;70:613-619.
27. Thompson P. Gait disorders accompanying diseases of the frontal lobes. Adv Neurol. 2001;87:235-241.
28. Baik J, Lang A. Gait abnormalities in psychogenic movement disorders. Mov Dis. 2007;22:395-399.
29. Crenna P, Carpinella I, Rabuffetti M, et al. The association between impaired turning and normal straight walking in Parkinson's disease. Gait Posture. 2007;26:172-178.
30. Sudarsky L. Psychogenic gait disorders. Semin Neurol. 2006;26:351-356.
31. Colledge NR, Wilson J. Authors' reply: Investigations to diagnose cause of dizziness in elderly people. BMJ. 1997;314:224-225.
32. Sterke C, Verhagen A, van Beeck E, van der Cammen T. The influence of drug use on fall incidents among nursing home residents; a systematic review. Int Psychogeriatr. 2008;17:1-21.
33. Thapa P, Gideon P, Cost T, et al. Antidepressants and the risk of falls among nursing home residents. N Engl J Med. 1998;339:875-882.
34. Babiy M, Stubblefield MD, Herklotz M, Hand M. Asterixis related to gabapentin as a cause of falls. Am J Phys Med Rehabil. 2005;84:136-140.
35. Beauchet O, Annweiler C, Dubost V, et al. Stops walking when talking: a predictor of falls in older adults? Eur J Neurol. 2009;16:786-795